WR304 mAb | 330021

WR304 Mouse Monoclonal Antibody (IgM)


100µg Aqueous

1 Ea

All Prices in US Dollars
This product Is pre-packaged in the unit sizes indicated above.
Quantity discounts are available at the 5 and 10 count level.
Add your chosen unit to the shopping cart and adjust the quantity to see the discount.

To purchase larger quantities of this product please contact our Customer Service Department

  • Product
  • Data
  • Downloads
  • Reference
  • Antibody Information
WR304 is an antibody that binds specifically to the lipids PIP and PIP2. WR304 also neutralizes infectious HIV-1 virus and can be used to probe the presence of PIP and PIP2 in membranes in a variety of applications including inositol phosphate-dependent cell signaling pathways.
This antibody was developed by the Walter Reed Army Institute of Research (WRAIR) using a targeted adjuvant protocol with liposomes containing Avanti’s Lipid A.
6 Months
The recommended long-term storage for WR304 is at -80°C. After initial thawing remaining product should refrozen at -80°C.
Wassef, N.M., F. Roerdink, G.M. Swartz Jr, J.A. Lyon, B.J. Berson, and C.R. Alving. (1984). Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes. Mol Immunol 21:863-8. [PubMed] Matyas, G.R., Z. Beck, N. Karasavvas, and C.R. Alving. (2009). Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. Biochim Biophys Acta 1788:660-5. [PubMed] Brown, B.K., N. Karasavvas, Z. Beck, G.R. Matyas, D.L. Birx, V.R. Polonis, and C.R. Alving. (2007). Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites. J Virol 81:2087-91. [PubMed] Beck, Z., N. Karasavvas, J. Tong, G.R. Matyas, M. Rao, and C.R. Alving. (2007). Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate. Biochem Biophys Res Commun 354:747-51. [PubMed]
Antigens: Brain PI(4)P. Ig Class: Mouse IgM (kappa). Specificity: WR304 recognizes PIP and PIP2, and neutralizes HIV-1 virus. Antibody Source: Monoclonal antibody from BALB/c-derived hybridoma WR304. Production: In vitro cell culture. Purification: Ultra filtration through 100 KDa cut-off filters. Purity: ≥ 95%. Formulation: WR304 is provided as a 0.2µm sterile-filtered solution in Tris buffered saline (TBS). WR304 binding to porcine brain PI(4)P is inhibited by high concentration of Ca2+ (10 mM)iv and addition of 1 mM EDTA stimulates this binding activity. PBS and other phosphate-containing buffers should not be used as they inhibit binding to the phospholipid head groupiii. Concentration: 1 mg/ml. Recommended Applications: ELISA, IHC, Dot Blot, Flow cytometry and HIV-1 infectivity. Storage conditions: Store undiluted at either -20°C or -80°C. Hazardous/Non-hazardous Components: This product contains no substances that, at their given concentration, are known to be hazardous to health. Therefore, there is no MSDS for this product.
Product use: The WR304 antibody has been used for the quantitation of PIP/PIP2 in direct ELISA and Dot Blot analysis. The WR304 antibody specifically binds to PIP/PIP2 and inhibits the infectivity of HIV-1 to peripheral blood mononuclear cells (PBMC).